C&R Research Services USA
Coral Gables, Florida 33134
0 studies enrolling now · 3 studies all time
What they study most
Atopic Dermatitis, Covid19, Cytokine Release Syndrome
Studies at this site
- Bucillamine in Treatment of Patients With COVID-19 — Stopped early
- Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome — Stopped early
- Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitis — Completed